Key points are not available for this paper at this time.
Analyses of at-risk cognitively normal populations suggest that we can reliably measure the first signs of cognitive decline with the ADCS-PACC. These analyses also suggest the feasibility of secondary prevention trials.
Building similarity graph...
Analyzing shared references across papers
Loading...
Michael Donohue
Reisa A. Sperling
David P. Salmon
JAMA Neurology
Harvard University
University of California, San Diego
University of California, San Francisco
Building similarity graph...
Analyzing shared references across papers
Loading...
Donohue et al. (Mon,) studied this question.
www.synapsesocial.com/papers/69d8cc1a17a1cc0598d1887a — DOI: https://doi.org/10.1001/jamaneurol.2014.803
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: